Seguir
David Haberl
David Haberl
Doctoral Researcher at the Medical University of Vienna
Dirección de correo verificada de meduniwien.ac.at - Página principal
Título
Citado por
Citado por
Año
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre …
CP Spielvogel*, D Haberl*, K Mascherbauer, J Ning, K Kluge, ...
The Lancet Digital Health 6 (4), e251-e260, 2024
112024
Artificial intelligence
J Cale, L Sloman
PDI, 1987
91987
Multicenter PET image harmonization using generative adversarial networks
D Haberl, CP Spielvogel, Z Jiang, F Orlhac, D Iommi, I Carrió, I Buvat, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-15, 2024
12024
Examining the Relationship and Prognostic Significance of Cell-Free DNA Levels and the PSMA-Positive Tumor Volume in Men with Prostate Cancer: A Retrospective–Prospective [68Ga …
K Kluge, H Einspieler, D Haberl, C Spielvogel, S Stoiber, C Vraka, L Papp, ...
Journal of Nuclear Medicine 65 (1), 63-70, 2024
12024
Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
K Kluge, D Haberl, H Einspieler, S Rasul, S Gutschmayer, L Kenner, ...
Journal of Nuclear Medicine 64 (11), 1730-1736, 2023
12023
DEBI-NN: Distance-encoding biomorphic-informational neural networks for minimizing the number of trainable parameters
L Papp, D Haberl, B Ecsedi, CP Spielvogel, D Krajnc, M Grahovac, ...
Neural Networks 167, 517-532, 2023
12023
A machine learning system for Gleason grading of prostate cancer improves patient stratification for radical prostatectomy: a multiomics diagnostic study
J Ning, C Spielvogel, K Tractova, D Haberl, S Rasul, S Stoiber, V Bystry, ...
Journal of Nuclear Medicine 64 (supplement 1), P594-P594, 2023
12023
Implementation and verification of Monte Carlo particle transport in electromagnetic fields in GATE
D Haberl
Wien, 2021
12021
Imaging Tumor Metabolism and Its Heterogeneity: Special Focus on Radiomics and AI
L Papp, D Haberl, B Ecsedi, M Hatt, E Lopci
2024
An instantly applicable machine learning model for extraprostatic extension prediction in prostate cancer: A post-hoc analysis of the RAPID 68Ga-PSMA PET/MRI trial
J Ning, C Spielvogel, K Kluge, D Haberl, G Wasinger, L Papp, ...
The PET is Wonderful Journal 1 (1), 2024
2024
Detection and risk stratification of cardiac amyloidosis patients by integration of imaging and non-imaging data using a machine learning approach
CP Spielvogel, D Haberl, K Kluge, K Mascherbauer, J Hennenberg, J Yu, ...
European Heart Journal 45 (Supplement_1), ehae666. 3459, 2024
2024
Systemic Metabolic and Volumetric Assessment via Whole-Body [18F]FDG-PET/CT: Pancreas Size Predicts Cachexia in Head and Neck Squamous Cell Carcinoma
J Yu, C Spielvogel, D Haberl, Z Jiang, Ö Özer, S Pusitz, B Geist, ...
Cancers 16 (19), 3352, 2024
2024
Incremental Role of Radiomics and Artificial Intelligence
L Papp, C Spielvogel, D Haberl, B Ecsedi
Advanced Imaging and Therapy in Neuro-Oncology, 161-172, 2024
2024
A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics study
J Ning, CP Spielvogel, D Haberl, K Trachtova, S Stoiber, S Rasul, V Bystry, ...
Theranostics 14 (12), 4570-4581, 2024
2024
Cardiac Amyloidosis Screening using Deep Learning on Bone Scintigraphy
CP Spielvogel, D Haberl, J Ning, K Kluge, X Li, X Ma, M Zhao, ...
Journal of Nuclear Medicine 65 (supplement 2), 241017-241017, 2024
2024
Insights from a medical algorithmic audit of a decision support system for the detection of cardiac amyloidosis on bone scintigraphy
CP Spielvogel, D Haberl, K Kluge, J Ning, M Hacker, C Nitsche
Journal of Nuclear Medicine 65 (supplement 2), 241741-241741, 2024
2024
Comparison of discovery rates and prognostic utility of [68Ga] Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer—a cross-sectional study
K Kluge, H Einspieler, D Haberl, C Spielvogel, D Amereller, G Egger, ...
European Journal of Nuclear Medicine and Molecular Imaging, 1-10, 2024
2024
Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [68Ga]Ga-PSMA-11-PET Examinations
H Einspieler, K Kluge, D Haberl, K Schatz, L Nics, S Schmitl, BK Geist, ...
Cancers 16 (8), 1514, 2024
2024
Prognose und Screening nach kardialer Amyloidose in der Knochenszintigrafie durch künstliche Intelligenz: Eine internationale, multizentrische, Tracer-übergreiffende Studie
CP Spielvogel, D Haberl, J Ning, K Kluge, T Traub-Weidinger, T Nakuz, ...
Nuklearmedizin-NuclearMedicine 63 (02), L03, 2024
2024
Quantum Image Analysis in PSMA-11 PET/CT Primary Prostate Patients
L Papp, D Haberl, M Hacker, W Drexler, S Moradi
Nuklearmedizin-NuclearMedicine 63 (02), V65, 2024
2024
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20